Lindbrook Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $9.57K | Hold |
1,190
| – | – | ﹤0.01% | 1670 |
|
|
2024
Q4 | $10.7K | Hold |
1,190
| – | – | ﹤0.01% | 1624 |
|
|
2024
Q3 | $8.72K | Hold |
1,190
| – | – | ﹤0.01% | 1744 |
|
|
2024
Q2 | $6.8K | Buy |
+1,190
| New | +$6.8K | ﹤0.01% | 1849 |
|
|
2024
Q1 | – | Sell |
-350
| Closed | -$3.15K | – | 2650 |
|
|
2023
Q4 | $3.15K | Sell |
350
-81
| -19% | -$728 | ﹤0.01% | 2094 |
|
|
2023
Q3 | $3.35K | Buy |
431
+169
| +65% | +$1.31K | ﹤0.01% | 1938 |
|
|
2023
Q2 | $2.54K | Hold |
262
| – | – | ﹤0.01% | 2058 |
|
|
2023
Q1 | $2.87K | Sell |
262
-5
| -2% | -$55 | ﹤0.01% | 2093 |
|
|
2022
Q4 | $1.15K | Buy |
+267
| New | +$1.15K | ﹤0.01% | 2432 |
|
|
2021
Q3 | – | Sell |
-4,000
| Closed | -$52K | – | 1850 |
|
|
2021
Q2 | $52K | Buy |
4,000
+1,000
| +33% | +$13K | 0.01% | 462 |
|
|
2021
Q1 | $39K | Sell |
3,000
-1,000
| -25% | -$13K | 0.01% | 520 |
|
|
2020
Q4 | $55K | Buy |
+4,000
| New | +$55K | 0.01% | 372 |
|
|
2020
Q3 | – | Sell |
-1,500
| Closed | -$24K | – | 1739 |
|
|
2020
Q2 | $24K | Buy |
+1,500
| New | +$24K | 0.01% | 548 |
|
|
2020
Q1 | – | Sell |
-3,500
| Closed | -$71K | – | 1682 |
|
|
2019
Q4 | $71K | Buy |
3,500
+2,000
| +133% | +$40.6K | 0.02% | 335 |
|
|
2019
Q3 | $8K | Sell |
1,500
-5,000
| -77% | -$26.7K | ﹤0.01% | 941 |
|
|
2019
Q2 | $42K | Buy |
6,500
+500
| +8% | +$3.23K | 0.02% | 464 |
|
|
2019
Q1 | $39K | Buy |
6,000
+4,000
| +200% | +$26K | 0.02% | 484 |
|
|
2018
Q4 | $13K | Buy |
+2,000
| New | +$13K | 0.01% | 740 |
|